Table 3.
ICSI data and clinical outcome of patients with different stages of endometriosis and control groups.
| Covariate | mean±SD | p-value | Eta
Squared (η2) |
||
|---|---|---|---|---|---|
| Endometriosis I/II n=124 |
Endometriosis III/IV n=96 |
Control n=220 |
|||
| FSH (mIU/L) | 7.82 ±4.92 | 8.27 ±7.74 | 6.13 ±2.20 | <0.001 | 0.04 |
| AMH(ng/mL) | 3.57 ±8.35 | 2.94 ±2.6 | 3.12 ±2.97 | 0.88 | 0.003 |
| Prolactin(ng/mL) | 17.17 ±11.62 | 19.38 ±12.93 | 14.72 ±6.14 | <0.001 | 0.05 |
| Total oocytes | 5.37 ±4.45 | 4.90 ±4.4 | 6.92 ±5.32 | <0.001 | 0.04 |
| Metaphase II oocytes | 2.52 ±3.53 | 2.07 ±3.04 | 4.60 ±4.6 | <0.001 | 0.09 |
| Total Embryos | 2.41 ±3.04 | 1.68 ±2.5 | 3.01 ±2.9 | 0.001 | 0.05 |
| Good quality embryos | 1.24 ±2 | 0.6 ±1.3 | 2.03 ±2.20 | <0.001 | 0.11 |
| Fertilization rate | 0.66 ±0.45 | 0.54±0.59 | 0.65 ±0.57 | 0.18 | 0.01 |
Data are expressed as mean ± SD.